Stay updated on MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page.

Latest updates to the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed, replacing the previous Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page footer revision was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedNew revision label v3.3.1 was added and the previous label v3.2.0 was removed from the page's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved a site-wide notice about government funding delays and potential interruptions that warned information may not be up to date.SummaryDifference0.4%

- Check76 days agoChange DetectedNew entries were added to the record history, reflecting recent updates with additional version dates. The core study details and statuses appear unchanged.SummaryDifference0.1%

Stay in the know with updates to MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page.